top of page
EPO 5000iu

 

Product Specification

Packaging SizeSingle
BrandEpofit
ManufacturerIntas Pharmaceuticals Ltd
CompositionErythropoietin 5000 IU
Treatmentchronic kidney failure
Prescription/Non prescriptionNon prescription
Medicine TypeInjection

 

Product Description

Erythropoietin 5000 IU.
This medication is a haematopoietic agent, prescribed for anemia in people with chronic kidney failure. It helps in the formation of red blood cells by the bone marrow.

 

Erythropoietin is indicated for the treatment of-

  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
  • Anemia related to therapy with zidovudine in HIV-infected patients.

Description

Erythropoietin (EPO) is a glycoprotein hormone, which is the primary regulator of red blood cell formation in mammals. Recombinant human erythropoietin (r-HuEPO) is a purified glycoprotein, produced from mammalian cells into which the gene coding for human erythropoietin has been inserted.

EPO 5000iu

£279.00Price
    bottom of page